相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Fibroblast growth factor 21 is induced by endoplasmic reticulum stress
Frank G. Schaap et al.
BIOCHIMIE (2013)
The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes
Gregory Gaich et al.
CELL METABOLISM (2013)
Fibroblast Growth Factor 21 Mediates Specific Glucagon Actions
Kirk M. Habegger et al.
DIABETES (2013)
Glucagon increases circulating fibroblast growth factor 21 independently of endogenous insulin levels: a novel mechanism of glucagon-stimulated lipolysis?
A. M. Arafat et al.
DIABETOLOGIA (2013)
Accuracy of Prediction Scores and Novel Biomarkers for Predicting Nonalcoholic Fatty Liver Disease in Obese Children
Bart G. P. Koot et al.
OBESITY (2013)
Activating transcription factor 4-dependent induction of FGF21 during amino acid deprivation
Ana Luisa De Sousa-Coelho et al.
BIOCHEMICAL JOURNAL (2012)
Fibroblast Growth Factor-21 Regulates PPARγ Activity and the Antidiabetic Actions of Thiazolidinediones
Paul A. Dutchak et al.
CELL (2012)
The Role of Bile After Roux-en-Y Gastric Bypass in Promoting Weight Loss and Improving Glycaemic Control
Dimitri J. Pournaras et al.
ENDOCRINOLOGY (2012)
Decrease in circulating fibroblast growth factor 21 after an oral fat load is related to postprandial triglyceride-rich lipoproteins and liver fat
Niina Matikainen et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Activation of the Farnesoid X Receptor Induces Hepatic Expression and Secretion of Fibroblast Growth Factor 21
Holly A. Cyphert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Conjugated Bile Acids Associate with Altered Rates of Glucose and Lipid Oxidation after Roux-en-Y Gastric Bypass
M. Simonen et al.
OBESITY SURGERY (2012)
Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity
Fredirick L. Mashili et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2011)
Alterations of Hormonally Active Fibroblast Growth Factors after Roux-en-Y Gastric Bypass Surgery
Peter L. M. Jansen et al.
DIGESTIVE DISEASES (2011)
Relation between fibroblast growth factor-21, adiposity, metabolism, and weight reduction
Knut Mai et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
FGF19 as a Postprandial, Insulin-Independent Activator of Hepatic Protein and Glycogen Synthesis
Serkan Kir et al.
SCIENCE (2011)
Physiological modulation of circulating FGF21: relevance of free fatty acids and insulin
Knut Mai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2010)
被撤回的出版物: Glucagon and lipid interactions in the regulation of hepatic AMPK signaling and expression of PPARα and FGF21 transcripts in vivo(Retracted article. See vol.311,pg.E850,2016)
Eric D. Berglund et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2010)
Intestinal adaptation after ileal interposition surgery increases bile acid recycling and protects against obesity-related comorbidities
Rohit Kohli et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2010)
Increased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty Liver Disease
Jody Dushay et al.
GASTROENTEROLOGY (2010)
Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1α pathway
Mary D. L. Chau et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity
M. Mraz et al.
CLINICAL ENDOCRINOLOGY (2009)
Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice
Jing Xu et al.
DIABETES (2009)
Circulating Fibroblast Growth Factor-21 Is Elevated in Impaired Glucose Tolerance and Type 2 Diabetes and Correlates With Muscle and Hepatic Insulin Resistance
Alberto O. Chavez et al.
DIABETES CARE (2009)
High Expression of the Bile Salt-Homeostatic Hormone Fibroblast Growth Factor 19 in the Liver of Patients with Extrahepatic Cholestasis
Frank G. Schaap et al.
HEPATOLOGY (2009)
The FGF family: biology, pathophysiology and therapy
Andrew Beenken et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Serum Bile Acids Are Higher in Humans With Prior Gastric Bypass: Potential Contribution to Improved Glucose and Lipid Metabolism
Mary-Elizabeth Patti et al.
OBESITY (2009)
The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARα activation in man
Cecilia Gaelman et al.
CELL METABOLISM (2008)
Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes
Blandine Laferrere et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity
Oded Shaham et al.
MOLECULAR SYSTEMS BIOLOGY (2008)
Hepatic fibroblast growth factor 21 is regulated by PPARα and is a key mediator of hepatic lipid metabolism in ketotic states
Michael K. Badman et al.
CELL METABOLISM (2007)
FGF-21 as a novel metabolic regulator
A Kharitonenkov et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Two days of a very low calorie diet reduces endogenous glucose production in obese type 2 diabetic patients despite the withdrawal of blood glucose-lowering therapies including insulin
IM Jazet et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2005)
分享论文
